Ted Pharmaceuticals seeks to raise up to 66 million US dollars through a Hong Kong IPO.

The listing documents of the Hong Kong Stock Exchange show that Ted Medicine plans to issue 16.8 million shares at a price of 28.4-30.6 Hong Kong dollars per share. The company is seeking to raise up to 514 million Hong Kong dollars. It is expected to debut on the stock market on June 30. Morgan Stanley and Citic Securities are acting as joint sponsors.